Who
Ryan J. Selhorn
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Aytu BioPharma.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Nov 2024
- Last trade
- 28 Jul 2026
- Last filed
- 30 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 Jul 2026filed 30 Jul 2026 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 28 Jul 2026filed 30 Jul 2026 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —16,243 at $0.00 | filing |
| 3 Oct 2025filed 7 Oct 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 5 Feb 2025filed 3 Mar 2025 | AYTU Aytu BioPharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —105 at $0.00 | filing |
| 5 Feb 2025filed 3 Mar 2025 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code M | —105 | filing |
| 11 Nov 2024filed 13 Nov 2024 | AYTU Aytu BioPharmaBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.